Analysis of NR5A1 in 142 patients with premature ovarian insufficiency, diminished ovarian reserve, or unexplained infertility.


Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 20 05 2019
revised: 26 07 2019
accepted: 28 10 2019
entrez: 3 12 2019
pubmed: 4 12 2019
medline: 18 3 2020
Statut: ppublish

Résumé

Ovarian deficiency, including diminished ovarian reserve and premature ovarian insufficiency, represents one of the main causes of female infertility. Little is known of the genetic basis of diminished ovarian reserve, while premature ovarian insufficiency often has a genetic basis, with genes affecting various processes. NR5A1 is a key gene required for gonadal function, and variants are associated with a wide phenotypic spectrum of disorders of sexual development, and are found in 0.26-8% of patients with premature ovarian insufficiency. As there is some debate about the extent of involvement of NR5A1 in the pathogenesis of ovarian deficiency, we performed an in-depth analysis of NR5A1 variants detected in a cohort of 142 patients with premature ovarian insufficiency, diminished ovarian reserve, or unexplained infertility associated with normal ovarian function. We identified rare non-synonymous protein-altering variants in 2.8 % of women with ovarian deficiency and no such variants in our small cohort of women with infertility but normal ovarian function. We observed previously reported variants associated with premature ovarian insufficiency in patients with diminished ovarian reserve, highlighting a genetic relationship between these conditions. We confirmed functional impairment resulting from a p.Val15Met variant, detected for the first time in a patient with premature ovarian insufficiency. The remaining variants were associated with preserved transcriptional activity and localization of NR5A1, indicating that rare NR5A1 variants may be incorrectly curated if functional studies are not undertaken, and/or that NR5A1 variants may have only a subtle impact on protein function and/or confer risk of ovarian deficiency via oligogenic inheritance.

Identifiants

pubmed: 31787151
pii: S0378-5122(19)30524-9
doi: 10.1016/j.maturitas.2019.10.011
pii:
doi:

Substances chimiques

NR5A1 protein, human 0
Steroidogenic Factor 1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-86

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Sylvie Jaillard (S)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia; Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France; CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France. Electronic address: sylvie.jaillard@chu-rennes.fr.

Rajini Sreenivasan (R)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.

Marion Beaumont (M)

CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France.

Gorjana Robevska (G)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.

Christèle Dubourg (C)

CHU Rennes, Service de Génétique Moléculaire, F-35033, Rennes, France.

Ingrid M Knarston (IM)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.

Linda Akloul (L)

CHU Rennes, Service de Génétique Clinique, CLAD Ouest, F-35033, Rennes, France.

Jocelyn van den Bergen (J)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.

Sylvie Odent (S)

CHU Rennes, Service de Génétique Clinique, CLAD Ouest, F-35033, Rennes, France.

Brittany Croft (B)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.

Guilhem Jouve (G)

CHU Rennes, Service de Biologie de la Reproduction, F-35033, Rennes, France.

Sonia R Grover (SR)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia; Department of Paediatric and Adolescent Gynaecology, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.

Solène Duros (S)

CHU Rennes, Département de Gynécologie Obstétrique et Reproduction Humaine, F-35033, Rennes, France.

Céline Pimentel (C)

CHU Rennes, Département de Gynécologie Obstétrique et Reproduction Humaine, F-35033, Rennes, France.

Marc-Antoine Belaud-Rotureau (MA)

Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France; CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France; CHU Rennes, Service de Biologie de la Reproduction, F-35033, Rennes, France.

Katie L Ayers (KL)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3052, Australia.

Célia Ravel (C)

Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France; CHU Rennes, Service de Biologie de la Reproduction, F-35033, Rennes, France.

Elena J Tucker (EJ)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3052, Australia.

Andrew H Sinclair (AH)

Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3052, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH